MARKET

CDXS

CDXS

Codexis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

15.06
+0.06
+0.40%
After Hours: 15.06 0 0.00% 16:27 11/15 EST
OPEN
15.10
PREV CLOSE
15.00
HIGH
15.18
LOW
14.79
VOLUME
262.28K
TURNOVER
--
52 WEEK HIGH
23.05
52 WEEK LOW
12.68
MARKET CAP
881.28M
P/E (TTM)
-69.6577
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CDXS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CDXS News

  • Edited Transcript of CDXS earnings conference call or presentation 5-Nov-19 9:30pm GMT
  • Thomson Reuters StreetEvents.16h ago
  • Codexis Squeaks Out a Profitable Quarter on Surging Product Revenue
  • MotleyFool.com.6d ago
  • Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
  • Zacks.11/06 14:00
  • Codexis, Inc. (CDXS) CEO John Nicols on Q3 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript.11/06 03:40

More

Industry

Biotechnology & Medical Research
+1.25%
Pharmaceuticals & Medical Research
+1.34%

Hot Stocks

Name
Price
%Change

About CDXS

Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.
More

Webull offers Codexis, Inc. (CDXS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.